Colon Cancer Clinical Trial
Real-time Computer-Aided Detection of Colonic Adenomas With NEC WISE VISION® Endoscopy
Summary
This is a prospective, multicenter, randomized study to evaluate the clinical performance of a novel CADe device, WISE VISION® Endoscopy System, in patients undergoing high-definition white light (HDWL) colonoscopy for screening or surveillance of colorectal Cancer (CRC).
Eligible subjects who meet the study inclusion/exclusion criteria will be randomized in a 1:1 ratio to undergo colonoscopy :
Experimental: CADe colonoscopy procedure with WISE VISION® Endoscopy (CADe Group)
Control: Standard Colonoscopy without CADe (Standard Colonoscopy Group)
Full Description
This study aims to evaluate whether NEC WISE VISION® Endoscopy enhances the ability to detect mucosal lesions when compared with the current standard-of-care procedure (high-definition white light [HDWL] colonoscopy). The CADe device, Wise VISION® Endoscopy, contains an artificial intelligence/machine learning (AI/ML) advanced algorithm to aid the endoscopists in detection of colonic lesions.
This study plans to enrol 830 subjects aged ≥ 45 years and < 75 years, who are scheduled for screening or surveillance colonoscopy.
After review of the inclusion and exclusion criteria, eligible subjects will be randomized in a 1:1 ratio to receive either computer-aided colonoscopy (CADe Group) or standard colonoscopy without CADe (Standard Colonoscopy Group).
All adenomas, that are identified during the colonoscopies, will be removed and biopsied as per standard clinical practice to assess adenoma miss rate, polyp miss rate, adenomas per colonoscopy and other endpoints.
Eligibility Criteria
Inclusion Criteria:
Patient is presenting to the endoscopy unit for colon cancer screening or surveillance colonoscopy.
Signed Informed Consent
Exclusion Criteria:
Contraindications to colonoscopy
Colonoscopy within the previous three (3) years
High-risk indications for colonoscopy
Antithrombotic therapy that cannot be stopped, precluding polyp resection
Inflammatory bowel disease
Referred for endoscopic mucosal resection (EMR)
Familial adenomatous polyposis syndrome or Serrated Polyposis Syndrome
Pregnant or planning a pregnancy during the study period
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 3 Locations for this study
How clear is this clinincal trial information?